• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Clearmind Medicine Inc (CSE: CMND )

    N/A UNCHANGED
    Last Price Updated: 3:54 PM EDT, Mar 14, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Clearmind Medicine Inc

    < Previous 1 2 3 4 Next >
    Israel-Based Clearmind Medicine Files Patent Applications for Three Unique Combinations of Future Psychedelic-Based Compounds
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    SciSparc and Clearmind Collaboration Strengthens IP Portfolio with Three Provisional Patent Applications in the US
    From SciSparc Ltd
    Via GlobeNewswire
    Israel-Based Clearmind Medicine Strengthening IP Portfolio with Three Provisional Patent Applications in the US
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Israel-Based Clearmind Medicine to Present at The OurCrowd Global Investor Summit Sponsored by Greenberg Traurig Tel Aviv
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Israeli- Based Clearmind Medicine to Host Virtual Investor Conference on Psychedelics for Obesity
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Israeli Biotech Clearmind Medicine Announces Positive Pre-Clinical Results Treating Major Depression With a Novel Ketamine-Based Compound
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Hebrew University' Yissum and Israeli Biotech Clearmind Medicine’s Psychedelic-Derived Obesity Treatment Presented by Professor Joseph Tam, D.M.D., Ph.D. at Isranalytica 2023
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Israel-Based Clearmind Successfully Completed Two R&D Projects With The Hebrew University of Jerusalem’s Tech Transfer Company, Yissum
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Israel-Based Clearmind Announces Additional Positive Results from the Third Part of its Pre-Clinical Study for Cocaine Addiction Treatment
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Israel-Based Clearmind Medicine Successfully Completes Production of CMND-100 Drug Candidate for Clinical Trial
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Israel-Based Clearmind Medicine Shows Efficacy of Psychedelic- Derived Obesity Treatment in Pre-Clinical Trial
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Israel-Based Clearmind Medicine Inc. CEO Discusses the Potential of Psychedelics for Addiction Treatment in Audio Interview with SmallCapVoice.com
    Via ACCESSWIRE
    Clearmind Medicine Inc.’s Psychedelic-Based Therapeutics Are Revolutionary To The Pharmaceutical Sector; Treating AUD In The Crosshairs ($CMND)
    Via AB Newswire
    Topics Intellectual Property
    Exposures Intellectual Property
    Clearmind Medicine Inc. Positions To Deliver A First-To-Market Psychedelic-Based Treatment For AUD ($CMND)
    Via AB Newswire
    Topics Intellectual Property
    Exposures Intellectual Property Product Safety
    Clearmind Medicine Announces Shareholders Meeting Results
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Israel-Based Clearmind Medicine Announces First Clinical Center to Join Its Clinical Trial for Alcohol Use Disorder
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Clearmind Medicine Inc. Scores Milestone Patent Issuance To Expedite And Protect Psychedelic-Based Treatment For AUD ($CMND)
    Via AB Newswire
    Topics Intellectual Property
    Exposures Intellectual Property
    Israel- Based Clearmind Medicine Granted U.S. Patent for Psychedelic-Based Alcohol Substitute
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Clearmind Medicine Inc. Is Disrupting The Pharmaceuticals Landscape; First-To-Market Psychedelic-Based Treatment For AUD In Its Crosshairs ($CMND)
    Via AB Newswire
    Israeli Based Biotech Company Clearmind Medicine Inc’s CEO, Dr. Adi Zuloff-Shani, Issues Letter to Shareholders
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Israeli Based Biotech Company Clearmind Completes IND-Enabling Studies for CMND-100
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Israeli Biotech Clearmind Medicine Appoints ex-Red Bull Executive Special Advisor for Developing MEAI as Alcohol Substitute
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming Clinical Trial
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Clearmind Medicine Announces Closing of US$7.5 Million Public Offering and Uplisting to the Nasdaq Capital Market
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Clearmind Medicine Announces Pricing of US$7.5 Million Public Offering and Uplisting to the Nasdaq Capital Market
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Clearmind Medicine Featured in "Psychedelics Tonight," Streaming on ALTRD.TV
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Rising Cases Of Mental Health Disorders of Stress, Anxiety & Addiction Fueling Need for Central Nervous System Therapeutics
    Palm Beach, FL – June 7, 2022 – FinancialNewsMedia.com News Commentary – The global Central Nervous System (CNS) treatments and its market revenues had been steadily growing pre-pandemic and are still... 
    Via FinancialNewsMedia
    Exposures COVID-19
    Global Psychedelics Market Is Expected To Reach $8 Billion By 2029
    Palm Beach, FL – May 24, 2022 – FinancialNewsMedia.com News Commentary – The Global psychedelic drugs market has been steadily rising for the past few years and is projected to continue at a faster... 
    Via FinancialNewsMedia
    InvestorNewsBreaks – Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) (OTC: CMNDF) to Host Third Event in Psychedelics for Alcoholism Series
    Via Investor Brand Network
    BioMedNewsBreaks – Clearmind Medicine Inc. (CSE: CMND) (OTC: CMNDF) (FSE: CWY0) Partners with Renowned Expert to Discuss Alcohol Use Disorder and Trauma at Upcoming Virtual Event
    Via Investor Brand Network
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.